Indefinite Delivery Contract 36C24226D0037
- Not listed
- The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Nuclear Diagnostic Products, Inc., a for-profit radiopharmaceutical supplier, to provide general radiopharmaceuticals to support nuclear medicine imaging procedures for the VA's Veterans Integrated Service Network (VISN) 2 healthcare system. The $4,038,178.15 IDC, which does not have a set-aside designation, has a period of performance through February 2026. Multiple firm fixed-price delivery orders...
- This federal contract IDV award is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) healthcare system. The prime contractor, Nuclear Diagnostic Products, Inc., is a for-profit organization specializing in providing critical medical imaging compounds used in nuclear medicine diagnostic procedures such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. The contract, which does not have a small business set-aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) awarded a single award indefinite delivery contract to Nuclear Diagnostic Products, Inc. to provide general radiopharmaceuticals. Under the contract, two firm fixed price delivery orders were issued for approximately $1.9 million and $2.2 million respectively to supply radiopharmaceutical products to VA medical centers in New York and New Jersey. The delivery orders have a...
- The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 16 (VISN 16) awarded a single-award Indefinite Delivery Contract (IDC) worth $2,692,693.25 to Numedrx Pharmacy Solutions LLC, a self-certified small disadvantaged business, for the provision of radiopharmaceutical supplies to support nuclear medicine diagnostic procedures for veterans. This IDC allows VISN 16 to issue firm fixed price delivery orders for these critical medical products as...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the procurement of nuclear medicine radiopharmaceuticals. The single-award IDC has a total contract ceiling of $220,000 and a performance period running through March 31, 2030. Jubilant Radiopharma, a for-profit small disadvantaged business, will provide a range of specialized...
- The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The $1.5 million IDC has an ultimate completion date of April 26, 2028 and was awarded on April 27, 2023. This contract enables the VA's Veterans Integrated Service Network (VISN) 10 to efficiently procure...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 6 (VISN 6), a civilian component of the Department of Veterans Affairs, on March 5, 2024, with a ceiling value of $2,604,741.98 and an ultimate completion date of March 4, 2029. The contract procures unit dose radiopharmaceuticals to support nuclear medicine diagnostic and therapeutic operations across VA medical...
- Petnet Solutions, Inc., a Siemens subsidiary headquartered in Knoxville, Tennessee, has been awarded a single-award Indefinite Delivery Contract by the Veterans Integrated Service Network 22 (VISN 22) of the Department of Veterans Affairs with a ceiling value of $556,595.00 for the base period extending from January 1, 2025, through December 31, 2026. The contract calls for the supply of radiopharmaceutical products, primarily fluorodeoxyglucose (F18 FDG) and sodium fluoride F-18, which are...
- This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract has a ceiling value of $39,846,211.35 and a period of performance ending on September 30, 2026. Jubilant Radiopharma will provide a range of radiopharmaceutical products, including Ga-68 Dotatate, iodine I-123,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a single award indefinite delivery contract to Advanced Accelerator Applications USA Inc. to provide radiopharmaceutical services and support. The contract has a potential value of $483,000 and period of performance through September 30, 2022. No set-aside was used for this award. Under the contract, the prime contractor has been issued two delivery orders. The first was for an...
Nuclear Diagnostic Products, Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network (VISN) 2, with a ceiling value of $959,170.05 and a performance period extending through December 31, 2026. The contract, which carries no small business set-aside designation, was awarded on February 22, 2026, following a pre-solicitation market research announcement released on January 7, 2026. The solicitation sought qualified contractors capable of supplying radiopharmaceutical products and related services to support nuclear medicine diagnostic and therapeutic procedures across six VA Medical Centers located in Manhattan, Brooklyn, Castle Point, East Orange, Northport, and the Bronx in New York and New Jersey. Eligible contractors were required to operate within North American Industry Classification System (NAICS) code 325412 (Pharmaceutical Preparation Manufacturing) and maintain a workforce of 1,300 employees or fewer. The contracted scope encompasses daily delivery of radiopharmaceuticals in both unit and bulk doses, quality control supplies, and comprehensive support services for nuclear medicine diagnostic and therapeutic procedures at the specified VA facilities. Nuclear Diagnostic Products, Inc., headquartered in Rockaway, New Jersey, specializes in supplying critical medical imaging compounds including specialized radiopharmaceuticals such as ILLUCCIX (Gallium 68 PSMA-11) and GA-68 NETSPOT utilized in positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. The company's extensive experience delivering radiopharmaceutical products through multiple existing Indefinite Delivery Contracts with the VA, including a concurrent $4,038,178.15 single-award IDC for general radiopharmaceuticals through February 2026, demonstrates established capability to meet the diagnostic imaging requirements of veteran healthcare facilities across multiple regional VA networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/23/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--65-NOTICE OF INTENT TO AWARD SOLE SOURCE RX - VISN 2 DOWNSTATE RADIOPHARMACEUTICALS | 36C24226Q0263 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Special Notice 2/3 | 1/13/26, 3:35 PM | |
6505--GENERAL RADIOPHARMACEUTICALS | 36C24226Q0263 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Award Notice 3/3 | 2/24/26, 1:14 PM | |
6505--6505 - VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS | 36C24226Q0263 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Pre-Solicitation 1/3 | 1/7/26, 11:32 AM |